About Dragon Pharmaceutical Inc.
Dragon Pharmaceutical, headquartered in Vancouver, Canada, is a leading manufacturer and distributor of a broad line of high-quality antibiotic products including 7-ACA, a key intermediate to produce cephalosporin antibiotics, clavulanic acid, and formulated cephalosporin antibiotic drugs. Dragon is the third largest 7-ACA producer and the first manufacturer and market leader of clavulanic acid products in China. Dragon utilizes its nationwide sales distribution network, close customer relationships, understanding of local markets and customer needs and low cost structure to outperform its international and domestic peers. With an annual capacity of 780 tons, Dragon is the largest exporter of 7-ACA in China. To learn more about Dragon Pharmaceutical Inc., please visit http://www.dragonpharma.com.
Safe Harbor Statement
This press release contains forward looking statements, including but
not limited to, that the Company will continue to experience growth in
sales of its main products, that it will continue to be able to improve its
production technology and efficiency, that it will continue to achieve
continuous growth in business and profitability in the near future. These
statements are subject to certain risks and uncertainties that could cause
actual results to differ materially from those anticipated in the forward
looking statements. Readers should not place undue reliance on forward
looking statements, which only reflect the views of management as of the
date hereof. The Company does not undertake the obligation to publicly
revise these forward looking statements to reflect subsequent events or
circumstances. Readers should carefully review the risk factors and other
factors described in its periodic reports filed with the Securities and
|SOURCE Dragon Pharmaceutical Inc.|
Copyright©2008 PR Newswire.
All rights reserved